LeMaitre Vascular Total Long Term Liabilities 2010-2024 | LMAT

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

LeMaitre Vascular total long term liabilities from 2010 to 2024. Total long term liabilities can be defined as the sum of all non-current liabilities.

LeMaitre Vascular Total Long Term Liabilities 2010-2024 | LMAT

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Total Assets Cash on Hand Long Term Debt Total Liabilities

LeMaitre Vascular total long term liabilities from 2010 to 2024. Total long term liabilities can be defined as the sum of all non-current liabilities.

Related Stocks
Company Name	Market Cap
Abbott Laboratories (ABT)	$203.4B
Stryker (SYK)	$148.7B
Boston Scientific (BSX)	$134.9B
EssilorLuxottica (ESLOY)	$111.5B
Medtronic (MDT)	$108.7B
Haleon (HLN)	$43.2B
Lonza Group Ag (LZAGY)	$42.4B
GE HealthCare Technologies (GEHC)	$37.5B
ResMed (RMD)	$35.8B
Terumo (TRUMY)	$29.4B
Koninklijke Philips (PHG)	$24.8B
Zimmer Biomet Holdings (ZBH)	$21.6B
Insulet (PODD)	$18.4B
Baxter (BAX)	$16.8B
Smith & Nephew SNATS (SNN)	$10.9B
BellRing Brands (BRBR)	$9.9B
Bio-Rad Laboratories (BIO)	$9.1B
Demant (WILYY)	$8.3B
Lantheus Holdings (LNTH)	$6.1B
TG Therapeutics (TGTX)	$5.4B
Haemonetics (HAE)	$4.3B
Prestige Consumer Healthcare (PBH)	$4.2B
ICU Medical (ICUI)	$4.1B
Perrigo (PRGO)	$3.7B
Envista Holdings (NVST)	$3.7B
Agios Pharmaceuticals (AGIO)	$3.2B
Neogen (NEOG)	$3.2B
Shandong Weigao Medical Polymer (SHWGF)	$3B
GN Store Nord (GNNDY)	$2.8B
QuidelOrtho (QDEL)	$2.5B